605016 Shandong Bailong Chuangyuan Bio-Tech
- 29.23
- +0.13+0.45%
Shandong Bailong Chuangyuan Bio-Tech News
Bailong Chuangyuan (605016.SH): As of May 10, 2024, the total number of shareholders of the company was 6,658
Gelonghui, May 13丨Bailong Chuangyuan (605016.SH) said on the investor interactive platform that as of May 10, 2024, the total number of shareholders of the company was 6,658.
Express News | Huafu Securities: There may be more room for alternatives to natural sweeteners in the future
Bailong Chuangyuan (605016): New production capacity combined with increased demand, sales of dietary fiber and healthy sweeteners surged year-on-year, and the performance was in line with expectations
Investment highlights: The company released its 2023 annual report, and the performance was in line with expectations. In 2023, the company achieved revenue of 868 million yuan (yoy +20.3%) and achieved net profit of 193 million yuan (yoy +28.0%)
Bailong Chuangyuan (605016): Excellent performance in 24Q1, production capacity implementation provides impetus for subsequent growth
Investment highlights The company's performance maintained steady growth in 2023, with excellent 24Q1 performance. In 2023, the company achieved revenue of 868 million yuan, +20.28% year-on-year; achieved net profit of 193 million yuan, year-on-year +
Bailong Chuangyuan (605016): 24Q1 creates a new high profit and seizes the opportunity to start production with new production capacity
Event: The company announced its 2023 annual report and 2024 quarterly report. In 2023, the company achieved revenue of 868 million yuan, +20.28% year on year; realized net profit of 193 million yuan, +27.9 million yuan year on year
Bailong Chuangyuan (605016): Steady profit growth in the first quarter of 2023 and 2024, implementation of new production capacity to promote sustainable development
Profitability grew rapidly in 2023, and the company's profit increased in the first quarter of 2024 compared to the same period last year. Bailong Chuangyuan is a leading manufacturer of prebiotics, dietary fiber, and healthy sweetener products in China. The company's main products include oligomers in the prebiotic sector
Bailong Chuangyuan (605016): Production capacity drives steady progress, new production capacity continues to drive performance growth
Event: The company released its 2023 annual report and 2024 quarterly report. In '23, the company achieved revenue of 868 million yuan, an increase of 20.28% over the previous year, and achieved net profit of 193 million yuan to mother, an increase of 28.02% over the previous year
Bailong Chuangyuan (605016): Steady growth in performance, optimistic about the commissioning of new projects
The company released its 2023 annual report and 2024 quarterly report. In 2023, it achieved revenue of 868 million yuan, +20.28% year over year, and net profit to mother of 193 million yuan, +27.98% year over year; 2024
Bailong Chuangyuan (605016.SH) announced its 2023 annual results, with net profit of 193 million yuan, an increase of 28.02% year-on-year
Bailong Chuangyuan (605016.SH) released the 2023 annual performance report. During the reporting period, the company achieved an operating income of 8...
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.'s (SHSE:605016) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) stock is up by a considerable 7.1% over the past week. Given the company's impressive performance, we decided to study its financial indicators m
Express News | The ban will be lifted next week, and the market value will exceed 130 billion yuan
About 124 million restricted shares of Bailong Chuangyuan (605016.SH) will be listed and circulated from April 22
Bailong Chuangyuan (605016.SH) announced that the shares with limited conditions of sale currently in circulation are all restricted shares of the company's initial public offering involving 2 shareholders, totaling approximately 124 million shares. The above shares have been locked for 36 months from the date of listing of the company's shares. The lockdown period is about to expire. The listing and circulation will commence on April 22, 2024 (since April 21, 2024 is a non-trading day, the listing and circulation date has been postponed to April 22, 2024).
Bailong Chuangyuan (605016.SH): As of April 10, 2024, the total number of shareholders of the company was 6,384
Gelonghui, April 11 | Bailong Chuangyuan (605016.SH) said on the investor interactive platform that as of April 10, 2024, the total number of shareholders of the company was 6,384.
The Returns At Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Aren't Growing
What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a perfect world, we'd like to see a company investing more capital into its business and
Bailong Chuangyuan (605016.SH): As of March 20, 2024, the total number of shareholders of the company was 6,475
Gelonghui March 21丨Bailong Chuangyuan (605016.SH) said on the investor interactive platform that as of March 20, 2024, the total number of shareholders of the company was 6,475.
Bailong Chuangyuan (605016.SH): As of March 8, 2024, the total number of shareholders of the company was 6,631
Gelonghui March 11 | Bailong Chuangyuan (605016.SH) said on the investor interactive platform that as of March 8, 2024, the total number of shareholders of the company was 6,631.
We Ran A Stock Scan For Earnings Growth And Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Passed With Ease
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Unfortunately, these high risk investment
Bailong Chuangyuan (605016.SH): As of February 29, 2024, the total number of shareholders of the company was 6332
Gelonghui March 5 | Bailong Chuangyuan (605016.SH) said on the investor interactive platform that as of February 29, 2024, the total number of shareholders of the company was 6,332.
Bailong Chuangyuan (605016) Review: Increased demand combined with the release of new project capacity drives the company's product sales growth performance in line with expectations
The company released the 2023 performance report, and the performance was in line with expectations. According to the company announcement, in 2023, the company achieved revenue of 868 million yuan (yoy +20.28%) and realized net profit of 193 million yuan (yoy+2)
Bailong Chuangyuan (605016): 2023 performance meets expectations to create a natural healthy functional sugar faucet
Matters: Company announcement: On February 27, 2024, the company released the 2023 annual performance report. The announcement showed that in 2023, the company achieved total operating revenue of 868 million yuan, an increase of 20.28% over the previous year; achieved business
Analysis
Price Target
No Data
